Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?

Journal Article · Tue May 15 04:00:00 EDT 2018 · International Journal of Radiation Oncology, Biology and Physics

DOI:https://doi.org/10.1016/J.IJROBP.2018.01.096· OSTI ID:23065596

Solberg, Arne ^[1]; Klepp, Olbjørn H. ^[2]; Myklebust, Tor Åge ^[3]; Skovlund, Eva ^[4]; Hoff, Solveig Roth ^[5]; Vatten, Lars J. ^[4]; Lund, Jo-Åsmund ^[1]

---

1. Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim (Norway)
2. Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund (Norway)
3. Department of Research and Innovation, Møre og Romsdal Hospital Trust, Ålesund (Norway)
4. Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim (Norway)
5. Department of Radiology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund (Norway)

Prostate cancer (PC) patients who undergo antiandrogen monotherapy are offered prophylactic radiation therapy (PRT) to the breast buds to avoid gynecomastia. The aim of the present study was to evaluate whether the risk of breast cancer (BC) in men with PC as their first cancer diagnosis was influenced by PRT.

• OSTI ID: 23065596
• Journal Information: International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 1 Vol. 101; ISSN IOBPD3; ISSN 0360-3016
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
ANTIANDROGENS
DIAGNOSIS
MAMMARY GLANDS
MEN
NEOPLASMS
PATIENTS
PROSTATE
RADIOTHERAPY